NASDAQ:IMMY - Imprimis Pharmaceuticals SEC Filings & 10K Form

Today's Range N/A
50-Day Range
$4.55
MA: $6.30
$8.70
52-Week Range N/A
Volume293,033 shs
Average Volume482,230 shs
Market Capitalization$181.82 million
P/E RatioN/A
Dividend YieldN/A
Beta-1.06

SEC Filings

Imprimis Pharmaceuticals (NASDAQ:IMMY) SEC Filings

DateFilerForm TypeView
09/12/2019
6:30 AM
Imprimis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2019
5:00 PM
Imprimis Pharmaceuticals (Issuer)
Kammer Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2019
6:30 AM
Imprimis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/30/2019
3:53 PM
Imprimis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2019
5:46 PM
Imprimis Pharmaceuticals (Issuer)
Kammer Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2019
3:16 PM
Imprimis Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/02/2019
7:00 AM
Imprimis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2019
6:00 AM
Imprimis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/30/2019
7:00 AM
Imprimis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/16/2019
5:53 PM
Imprimis Pharmaceuticals (Issuer)
Kammer Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2019
8:07 PM
Imprimis Pharmaceuticals (Issuer)
Principi Anthony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2019
8:06 PM
Imprimis Pharmaceuticals (Issuer)
Kammer Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2019
8:05 PM
Imprimis Pharmaceuticals (Issuer)
LINDSTROM RICHARD L MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2019
8:04 PM
AUSTIN STEPHEN G (Reporting)
Imprimis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2019
4:00 PM
Imprimis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2019
6:08 PM
Imprimis Pharmaceuticals (Issuer)
Kammer Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2019
6:30 AM
Imprimis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/29/2019
6:30 AM
Imprimis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2019
7:00 AM
Imprimis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/17/2019
5:30 AM
Imprimis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2019
3:30 PM
Imprimis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2019
3:30 PM
Imprimis Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/03/2019
4:15 PM
Imprimis Pharmaceuticals (Issuer)
Kammer Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/25/2019
4:00 PM
Imprimis Pharmaceuticals (Filer)
Form DEF 14A
04/15/2019
4:01 PM
Imprimis Pharmaceuticals (Filer)
Form PRE 14A
04/02/2019
4:10 PM
Imprimis Pharmaceuticals (Issuer)
Kammer Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2019
7:00 AM
Imprimis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2019
3:20 PM
Imprimis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2019
3:16 PM
Imprimis Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/04/2019
5:00 PM
Imprimis Pharmaceuticals (Issuer)
Kammer Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2019
6:00 AM
Imprimis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/25/2019
7:00 AM
Imprimis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2019
6:47 PM
Imprimis Pharmaceuticals (Issuer)
SAHAREK JOHN P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2019
6:45 PM
BOLL ANDREW R. (Reporting)
Imprimis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2019
6:44 PM
BAUM MARK L (Reporting)
Imprimis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2019
3:01 PM
Imprimis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2019
6:05 AM
Imprimis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/01/2019
5:00 PM
Imprimis Pharmaceuticals (Issuer)
Kammer Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2018
6:00 AM
Imprimis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2018
5:15 AM
Imprimis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2018
5:09 AM
Imprimis Pharmaceuticals (Issuer)
Kammer Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/23/2018
5:15 AM
Eton Pharmaceuticals, Inc. (Subject)
Imprimis Pharmaceuticals (Filed by)
Form SC 13D
11/13/2018
4:41 PM
Eton Pharmaceuticals, Inc. (Issuer)
Imprimis Pharmaceuticals (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/13/2018
3:20 PM
Imprimis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2018
3:17 PM
Imprimis Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2018
11:00 AM
Imprimis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2018
6:15 AM
Imprimis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/02/2018
5:20 PM
Imprimis Pharmaceuticals (Issuer)
Kammer Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/29/2018
5:11 AM
Imprimis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/18/2018
8:10 AM
Imprimis Pharmaceuticals (Issuer)
Kammer Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/07/2018
4:25 PM
Imprimis Pharmaceuticals (Subject)
Opaleye Management Inc. (Filed by)
Form SC 13G
09/05/2018
6:45 PM
Imprimis Pharmaceuticals (Issuer)
Kammer Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2018
5:05 AM
Imprimis Pharmaceuticals (Issuer)
Kammer Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2018
5:15 AM
Imprimis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2018
6:00 AM
Imprimis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2018
3:20 PM
Imprimis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2018
3:16 PM
Imprimis Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/25/2018
6:30 AM
Imprimis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2018
6:52 PM
Imprimis Pharmaceuticals (Issuer)
LINDSTROM RICHARD L MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2018
6:48 PM
Imprimis Pharmaceuticals (Issuer)
Kammer Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2018
6:47 PM
Imprimis Pharmaceuticals (Issuer)
Principi Anthony (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2018
6:43 PM
AUSTIN STEPHEN G (Reporting)
Imprimis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2018
4:22 PM
Imprimis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/01/2018
6:00 AM
Imprimis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2018
6:30 AM
Imprimis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/13/2018
7:00 AM
Imprimis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/12/2018
3:38 PM
Imprimis Pharmaceuticals (Filer)
Form PRE 14A
03/12/2018
6:30 AM
Imprimis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/08/2018
3:25 PM
Imprimis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/08/2018
3:23 PM
Imprimis Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/08/2018
11:15 AM
Conrad Brett (Reporting)
Imprimis Pharmaceuticals (Issuer)
Longboard Capital Advisors, LLC (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/02/2018
8:00 PM
Imprimis Pharmaceuticals (Issuer)
SAHAREK JOHN P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2018
7:58 PM
BOLL ANDREW R. (Reporting)
Imprimis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2018
6:00 AM
Imprimis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2018
5:30 PM
Imprimis Pharmaceuticals (Issuer)
SAHAREK JOHN P. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2018
5:30 PM
BOLL ANDREW R. (Reporting)
Imprimis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2018
5:30 PM
BAUM MARK L (Reporting)
Imprimis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 9/16/2019 by MarketBeat.com Staff

Featured Article: Call Option Volume

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel